Literature DB >> 35079596

Rationale and protocol for a pilot randomized controlled trial of a cognitive prescription intervention for reducing dementia risk factors among African Americans.

Pariya L Fazeli1, Cierra Hopkins1, David E Vance1, Virginia Wadley2, Peng Li1, Bulent Turan3, Pamela G Bowen1, Olivio J Clay3.   

Abstract

BACKGROUND &
PURPOSE: African Americans (AAs) are twice as likely to develop dementia than Whites, which may be driven by poorer dementia knowledge and lifestyle factors. This article provides the rationale and protocol for a pilot clinical trial examining a tailored multi-domain lifestyle modification intervention in middle-aged and older AAs. This study will explore the feasibility and efficacy of individualized Cognitive Prescriptions (CogRx) which target five domains: physical activity, cognitive activity, diet, sleep, and social activity. Theoretical underpinnings include Social Cognitive Theory and the Health Belief Model, which suggest that tailored risk factor information, goal-setting, and outcome expectations along with addressing self-efficacy and barriers will promote behavior change. STUDY
DESIGN: This study plans to enroll 150 community-dwelling AA participants aged 45-65 without significant cognitive impairment. After baseline assessment including data-driven assessment of deficiencies in each of the five CogRx domains, participants are randomized with equal allocation to either: psychoeducation + CogRx, psychoeducation only, or no-contact control. The psychoeducation and CogRx groups receive general psychoeducation on dementia prevalence, prognosis, and risk factors, while the CogRx group also receives information on their risk factor profile and develops a tailored 3-month intervention plan, consisting of simple evidence-based strategies to implement. The CogRx condition receives text-messaging reminders and adherence queries and provides feedback on this program.
CONCLUSION: This study tests a novel multi-domain dementia prevention intervention and has several strengths, including enrolling middle-aged AAs with a focus on prevention, assessing adherence and self-efficacy, tailoring the intervention, and examining dementia knowledge. The goal is to yield new perspectives on person-centered dementia prevention approaches in diverse populations, and ultimately impact clinical and public health recommendations for maintaining cognitive health, thereby reducing disparities in dementia. Modifications to study design due to COVID-19 and future directions are discussed.

Entities:  

Keywords:  health behaviors; health literacy; lifestyle; minorities

Year:  2022        PMID: 35079596      PMCID: PMC8783962          DOI: 10.2147/nrr.s339200

Source DB:  PubMed          Journal:  Nursing (Auckl)        ISSN: 2230-522X


  68 in total

1.  The Philadelphia Geriatric Center Morale Scale: a revision.

Authors:  M P Lawton
Journal:  J Gerontol       Date:  1975-01

2.  Mental, physical and social components in leisure activities equally contribute to decrease dementia risk.

Authors:  Anita Karp; Stephanie Paillard-Borg; Hui-Xin Wang; Merril Silverstein; Bengt Winblad; Laura Fratiglioni
Journal:  Dement Geriatr Cogn Disord       Date:  2005-11-23       Impact factor: 2.959

3.  Lifecourse social conditions and racial and ethnic patterns of cognitive aging.

Authors:  M Maria Glymour; Jennifer J Manly
Journal:  Neuropsychol Rev       Date:  2008-09-25       Impact factor: 7.444

4.  Text messaging to motivate walking in older African Americans: a randomized controlled trial.

Authors:  Bang Hyun Kim; Karen Glanz
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

5.  Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults.

Authors:  P M Lewinsohn; J R Seeley; R E Roberts; N B Allen
Journal:  Psychol Aging       Date:  1997-06

Review 6.  Disclosure of traumas and psychosomatic processes.

Authors:  J W Pennebaker; J R Susman
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

7.  The Alzheimer's Disease Knowledge Scale: development and psychometric properties.

Authors:  Brian D Carpenter; Steve Balsis; Poorni G Otilingam; Priya K Hanson; Margaret Gatz
Journal:  Gerontologist       Date:  2009-03-25

8.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

Authors:  Eric M Reiman; Yakeel T Quiroz; Adam S Fleisher; Kewei Chen; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Anne M Fagan; Aarti R Shah; Sergio Alvarez; Andrés Arbelaez; Margarita Giraldo; Natalia Acosta-Baena; Reisa A Sperling; Brad Dickerson; Chantal E Stern; Victoria Tirado; Claudia Munoz; Rebecca A Reiman; Matthew J Huentelman; Gene E Alexander; Jessica B S Langbaum; Kenneth S Kosik; Pierre N Tariot; Francisco Lopera
Journal:  Lancet Neurol       Date:  2012-11-06       Impact factor: 44.182

9.  COVID-19 Is Disproportionately High in African Americans. This Will Come as No Surprise….

Authors:  Mona N Fouad; John Ruffin; Selwyn M Vickers
Journal:  Am J Med       Date:  2020-05-20       Impact factor: 4.965

10.  Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey.

Authors:  Pascal Geldsetzer
Journal:  Ann Intern Med       Date:  2020-03-20       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.